<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39236155</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>386</Volume><Issue>6720</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>25</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Hematopoietic aging promotes cancer by fueling IL-1&#x237a;-driven emergency myelopoiesis.</ArticleTitle><Pagination><StartPage>eadn0327</StartPage><MedlinePgn>eadn0327</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1126/science.adn0327</ELocationID><Abstract><AbstractText>Age is a major risk factor for cancer, but how aging impacts tumor control remains unclear. In this study, we establish that aging of the immune system, regardless of the age of the stroma and tumor, drives lung cancer progression. Hematopoietic aging enhances emergency myelopoiesis, resulting in the local accumulation of myeloid progenitor-like cells in lung tumors. These cells are a major source of interleukin (IL)-1&#x237a;, which drives the enhanced myeloid response. The age-associated decline of DNA methyltransferase 3A enhances IL-1&#x237a; production, and disrupting IL-1 receptor 1 signaling early during tumor development normalized myelopoiesis and slowed the growth of lung, colonic, and pancreatic tumors. In human tumors, we identified an enrichment for IL-1&#x237a;-expressing monocyte-derived macrophages linked to age, poorer survival, and recurrence, unraveling how aging promotes cancer and offering actionable therapeutic strategies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Matthew D</ForeName><Initials>MD</Initials><Identifier Source="ORCID">0000-0003-3488-3262</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Le Berichel</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-0846-3280</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Hamon</LastName><ForeName>Pauline</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-6776-1635</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wilk</LastName><ForeName>C Matthias</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0001-5429-7143</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Belabed</LastName><ForeName>Meriem</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yatim</LastName><ForeName>Nader</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-5326-1624</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saffon</LastName><ForeName>Alexis</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7771-4229</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U932, Immunity and Cancer, Institut Curie, Paris-Cit&#xe9; University, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boumelha</LastName><ForeName>Jesse</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-7635-2537</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falcomat&#xe0;</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-9269-2582</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tepper</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1384-9241</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hegde</LastName><ForeName>Samarth</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6319-0372</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mattiuz</LastName><ForeName>Rapha&#xeb;l</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-3292-1635</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soong</LastName><ForeName>Brian Y</ForeName><Initials>BY</Initials><Identifier Source="ORCID">0000-0003-4647-7704</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>LaMarche</LastName><ForeName>Nelson M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rentzeperis</LastName><ForeName>Frederika</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-9797-1134</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Troncoso</LastName><ForeName>Leanna</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-2529-9267</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halasz</LastName><ForeName>Laszlo</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-4726-7012</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hennequin</LastName><ForeName>Clotilde</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chin</LastName><ForeName>Theodore</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-1720-4117</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Earnest P</ForeName><Initials>EP</Initials><Identifier Source="ORCID">0000-0002-1626-5551</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reid</LastName><ForeName>Amanda M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0009-9689-5446</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cahn</LastName><ForeName>Ashley Reid</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koekkoek</LastName><ForeName>Laura L</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain and Body Research Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venturini</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wood-Isenberg</LastName><ForeName>Shira</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'souza</LastName><ForeName>Darwin</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-1943-5173</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><Identifier Source="ORCID">0009-0004-0021-2561</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dawson</LastName><ForeName>Travis</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-9609-793X</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nie</LastName><ForeName>Kai</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-8253-9688</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhihong</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0001-7403-7015</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim-Schulze</LastName><ForeName>Seunghee</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0192-4400</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casanova-Acebes</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5790-1163</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swirski</LastName><ForeName>Filip K</ForeName><Initials>FK</Initials><Identifier Source="ORCID">0000-0002-3163-9152</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain and Body Research Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Downward</LastName><ForeName>Julian</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2331-4729</Identifier><AffiliationInfo><Affiliation>Oncogene Biology Laboratory, Francis Crick Institute, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lung Cancer Group, Division of Molecular Pathology, Institute of Cancer Research, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vabret</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Brian D</ForeName><Initials>BD</Initials><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marron</LastName><ForeName>Thomas U</ForeName><Initials>TU</Initials><Identifier Source="ORCID">0000-0001-5903-8191</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Thoracic Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merad</LastName><ForeName>Miriam</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4481-7827</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CC2097</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>U01 CA282114</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K00 CA223043</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL122285</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA257195</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U2C ES030859</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 CA224319</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DA055434</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL166720</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA254104</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA277479</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA196521</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.1.1.37</RegistryNumber><NameOfSubstance UI="D000090205">DNA Methyltransferase 3A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053582">Interleukin-1alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053583">Interleukin-1beta</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="Y">Aging</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000090205" MajorTopicYN="Y">DNA Methyltransferase 3A</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006410" MajorTopicYN="N">Hematopoiesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053582" MajorTopicYN="Y">Interleukin-1alpha</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053583" MajorTopicYN="N">Interleukin-1beta</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="Y">Lung Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="Y">Macrophages</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D038042" MajorTopicYN="Y">Myelopoiesis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010190" MajorTopicYN="N">Pancreatic Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>
<b>Competing interests</b>
. MM serves on the scientific advisory board and hold stock from Compugen Inc., Dynavax Inc., Innate Pharma Inc., Morphic Therapeutics, Asher Bio Inc., Dren Bio Inc., Nirogy Inc., Genenta Inc., Oncoresponse, Inc., and Owkin Inc. MM serves on the ad hoc scientific advisory board of DBV Inc. and Genentech Inc. and on the foundation advisory board of Breakthrough Cancer. MM receives funding for contracted research from Genentech Inc., Regeneron Inc., and Boehringer Ingelheim Inc. MM is listed as an inventor on a patent application (#16/092576) submitted by the Icahn School of Medicine at Mount Sinai that covers the use of multiplex immunohistochemistry to characterize tumors and treatment responses. The technology is filed through the Icahn School of Medicine at Mount Sinai (ISMMS) and is currently unlicensed. This technology was used to evaluate tissue in this study, and the results could impact the value of this technology. TUM has served on Advisory and/or Data Safety Monitoring Boards for Rockefeller University, Regeneron Pharmaceuticals, Abbvie, Bristol-Meyers Squibb, Boehringer Ingelheim, Atara, AstraZeneca, Genentech, Celldex, Chimeric, Glenmark, Simcere, Surface, G1 Therapeutics, NGMbio, DBV Technologies, Arcus, and Astellas, and has research grants from Regeneron, Bristol-Myers Squibb, Merck, and Boehringer Ingelheim. The remaining authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>4</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>5</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>5</Day><Hour>14</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39236155</ArticleId><ArticleId IdType="mid">EMS199319</ArticleId><ArticleId IdType="pmc">PMC7616710</ArticleId><ArticleId IdType="doi">10.1126/science.adn0327</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pilleron S, Soto-Perez-de-Celis E, Vignat J, Ferlay J, Soerjomataram I, Bray F, Sarfati D. Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050. Int J Cancer. 2021;148:601&#x2013;608. doi: 10.1002/ijc.33232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.33232</ArticleId><ArticleId IdType="pmc">PMC7754149</ArticleId><ArticleId IdType="pubmed">32706917</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Ot&#xed;n C, Pietrocola F, Roiz-Valle D, Galluzzi L, Kroemer G. Meta-hallmarks of aging and cancer. Cell Metab. 2023;35:12&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">36599298</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z, Wang J, Feng L, Yang X, Qi Q, Li W, Zhang X, Ge M, Qin H. Association of tumor mutational burden with age in solid tumors. J Clin Orthod. 2020;38:e13590</Citation></Reference><Reference><Citation>Klutstein M, Moss J, Kaplan T, Cedar H. Contribution of epigenetic mechanisms to variation in cancer risk among tissues. Proceedings of the National Academy of Sciences. 2017;114:2230&#x2013;2234. doi: 10.1073/pnas.1616556114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1616556114</ArticleId><ArticleId IdType="pmc">PMC5338490</ArticleId><ArticleId IdType="pubmed">28193856</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomasetti C, Li L, Vogelstein B. Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention. Science. 2017;355:1330&#x2013;1334. doi: 10.1126/science.aaf9011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf9011</ArticleId><ArticleId IdType="pmc">PMC5852673</ArticleId><ArticleId IdType="pubmed">28336671</ArticleId></ArticleIdList></Reference><Reference><Citation>Han S, Georgiev P, Ringel AE, Sharpe AH, Haigis MC. Age-associated remodeling of T cell immunity and metabolism. Cell Metab. 2023;35:36&#x2013;55. doi: 10.1016/j.cmet.2022.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2022.11.005</ArticleId><ArticleId IdType="pmc">PMC10799654</ArticleId><ArticleId IdType="pubmed">36473467</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM, Epel ES, Franceschi C, Lithgow GJ, Morimoto RI, Pessin JE, Rando TA, et al. Geroscience: linking aging to chronic disease. Cell. 2014;159:709&#x2013;713. doi: 10.1016/j.cell.2014.10.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.10.039</ArticleId><ArticleId IdType="pmc">PMC4852871</ArticleId><ArticleId IdType="pubmed">25417146</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15:505&#x2013;522. doi: 10.1038/s41569-018-0064-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-018-0064-2</ArticleId><ArticleId IdType="pmc">PMC6146930</ArticleId><ArticleId IdType="pubmed">30065258</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider JL, Rowe JH, Garcia-de-Alba C, Kim CF, Sharpe AH, Haigis MC. The aging lung: Physiology, disease, and immunity. Cell. 2021;184:1990&#x2013;2019. doi: 10.1016/j.cell.2021.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.03.005</ArticleId><ArticleId IdType="pmc">PMC8052295</ArticleId><ArticleId IdType="pubmed">33811810</ArticleId></ArticleIdList></Reference><Reference><Citation>Lichtenstein MRL, Nipp RD, Muzikansky A, Goodwin K, Anderson D, Newcomb RA, Gainor JF. Impact of Age on Outcomes with Immunotherapy in Patients with Non-Small Cell Lung Cancer. J Thorac Oncol. 2019;14:547&#x2013;552.</Citation><ArticleIdList><ArticleId IdType="pubmed">30476576</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Z, Zhu C, Wang H, Ji M, Huang Y, Wei X, Zhang J, Wang Y, Yin R, Dai J, Xu L, et al. Association between biological aging and lung cancer risk: Cohort study and Mendelian randomization analysis. iScience. 2023;26:106018. doi: 10.1016/j.isci.2023.106018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2023.106018</ArticleId><ArticleId IdType="pmc">PMC9958377</ArticleId><ArticleId IdType="pubmed">36852276</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco R, Maestu I, de la Torre MG, Cassinello A, Nu&#xf1;ez I. A review of the management of elderly patients with non-small-cell lung cancer. Ann Oncol. 2015;26:451&#x2013;463.</Citation><ArticleIdList><ArticleId IdType="pubmed">25060421</ArticleId></ArticleIdList></Reference><Reference><Citation>Boumelha J, de Carn&#xe9; Tr&#xe9;cesson S, Law EK, Romero-Clavijo P, Coelho MA, Ng KW, Mugarza E, Moore C, Rana S, Caswell DR, Murillo M, et al. An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations. Cancer Res. 2022;82:3435&#x2013;3448. doi: 10.1158/0008-5472.CAN-22-0325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-22-0325</ArticleId><ArticleId IdType="pmc">PMC7613674</ArticleId><ArticleId IdType="pubmed">35930804</ArticleId></ArticleIdList></Reference><Reference><Citation>Park MD, Silvin A, Ginhoux F, Merad M. Macrophages in health and disease. Cell. 2022;185:4259&#x2013;4279. doi: 10.1016/j.cell.2022.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.10.007</ArticleId><ArticleId IdType="pmc">PMC9908006</ArticleId><ArticleId IdType="pubmed">36368305</ArticleId></ArticleIdList></Reference><Reference><Citation>Aegerter H, Kulikauskaite J, Crotta S, Patel H, Kelly G, Hessel EM, Mack M, Beinke S, Wack A. Influenza-induced monocyte-derived alveolar macrophages confer prolonged antibacterial protection. Nat Immunol. 2020;21:145&#x2013;157. doi: 10.1038/s41590-019-0568-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-019-0568-x</ArticleId><ArticleId IdType="pmc">PMC6983324</ArticleId><ArticleId IdType="pubmed">31932810</ArticleId></ArticleIdList></Reference><Reference><Citation>Machiels B, Dourcy M, Xiao X, Javaux J, Mesnil C, Sabatel C, Desmecht D, Lallemand F, Martinive P, Hammad H, Guilliams M, et al. A gammaherpesvirus provides protection against allergic asthma by inducing the replacement of resident alveolar macrophages with regulatory monocytes. Nat Immunol. 2017;18:1310&#x2013;1320.</Citation><ArticleIdList><ArticleId IdType="pubmed">29035391</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Gu Y, Chakarov S, Bleriot C, Kwok I, Chen X, Shin A, Huang W, Dress RJ, Dutertre C-A, Schlitzer A, et al. Fate Mapping via Ms4a3-Expression History Traces Monocyte-Derived Cells. Cell. 2019;178:1509&#x2013;1525.:e19.</Citation><ArticleIdList><ArticleId IdType="pubmed">31491389</ArticleId></ArticleIdList></Reference><Reference><Citation>Ad&#xe9; K, Coronilla JS, Obino D, Weinberger T, Kaiser C, Mella S, Chen C, Katsimpardi L, Werts C, Li H, Dardenne P, et al. Inflammation drives age-induced loss of tissue resident macrophages. bioRxiv. 2022:2022.10.02.510513</Citation></Reference><Reference><Citation>Shchukina I, Bagaitkar J, Shpynov O, Loginicheva E, Porter S, Mogilenko DA, Wolin E, Collins P, Demidov G, Artomov M, Zaitsev K, et al. Enhanced epigenetic profiling of classical human monocytes reveals a specific signature of healthy aging in the DNA methylome. Nat Aging. 2021;1:124&#x2013;141. doi: 10.1038/s43587-020-00002-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43587-020-00002-6</ArticleId><ArticleId IdType="pmc">PMC8597198</ArticleId><ArticleId IdType="pubmed">34796338</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto K, Kouno T, Ikawa T, Hayatsu N, Miyajima Y, Yabukami H, Terooatea T, Sasaki T, Suzuki T, Valentine M, Pascarella G, et al. Single-cell transcriptomics reveals expansion of cytotoxic CD4 T cells in supercentenarians. Proc Natl Acad Sci U S A. 2019;116:24242&#x2013;24251. doi: 10.1073/pnas.1907883116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1907883116</ArticleId><ArticleId IdType="pmc">PMC6883788</ArticleId><ArticleId IdType="pubmed">31719197</ArticleId></ArticleIdList></Reference><Reference><Citation>Terekhova M, Swain A, Bohacova P, Aladyeva E, Arthur L, Laha A, Mogilenko DA, Burdess S, Sukhov V, Kleverov D, Echalar B, et al. Single-cell atlas of healthy human blood unveils age-related loss of NKG2C+GZMB-CD8+ memory T cells and accumulation of type 2 memory T cells. Immunity. 2023;56:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">37963457</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y, et al. A human circulating immune cell landscape in aging and COVID-19. Protein Cell. 2020;11:740&#x2013;770. doi: 10.1007/s13238-020-00762-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-020-00762-2</ArticleId><ArticleId IdType="pmc">PMC7417788</ArticleId><ArticleId IdType="pubmed">32780218</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y, et al. Phenotypic and functional alterations of monocyte subsets with aging. Immun Ageing. 2022;19:63. doi: 10.1186/s12979-022-00321-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-022-00321-9</ArticleId><ArticleId IdType="pmc">PMC9745938</ArticleId><ArticleId IdType="pubmed">36514074</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghi HM, Schnelle JF, Thomas JK, Nishanian P, Fahey JL. Phenotypic and functional characteristics of circulating monocytes of elderly persons&#x2606;. Exp Gerontol. 1999;34:959&#x2013;970.</Citation><ArticleIdList><ArticleId IdType="pubmed">10673149</ArticleId></ArticleIdList></Reference><Reference><Citation>Trzebanski S, Kim J-S, Larossi N, Raanan A, Kancheva D, Bastos J, Haddad M, Solomon A, Sivan E, Aizik D, Kralova JS, et al. Classical monocyte ontogeny dictates their functions and fates as tissue macrophages. Immunity. 2024</Citation><ArticleIdList><ArticleId IdType="pubmed">38986443</ArticleId></ArticleIdList></Reference><Reference><Citation>Beerman I, Bhattacharya D, Zandi S, Sigvardsson M, Weissman IL, Bryder D, Rossi DJ. Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc Natl Acad Sci U S A. 2010;107:5465&#x2013;5470. doi: 10.1073/pnas.1000834107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1000834107</ArticleId><ArticleId IdType="pmc">PMC2851806</ArticleId><ArticleId IdType="pubmed">20304793</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang WW, Price EA, Sahoo D, Beerman I, Maloney WJ, Rossi DJ, Schrier SL, Weissman IL. Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc Natl Acad Sci U S A. 2011;108:20012&#x2013;20017. doi: 10.1073/pnas.1116110108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1116110108</ArticleId><ArticleId IdType="pmc">PMC3250139</ArticleId><ArticleId IdType="pubmed">22123971</ArticleId></ArticleIdList></Reference><Reference><Citation>Beerman I, Bock C, Garrison BS, Smith ZD, Gu H, Meissner A, Rossi DJ. Proliferation-dependent alterations of the DNA methylation landscape underlie hematopoietic stem cell aging. Cell Stem Cell. 2013;12:413&#x2013;425.</Citation><ArticleIdList><ArticleId IdType="pubmed">23415915</ArticleId></ArticleIdList></Reference><Reference><Citation>LaMarche NM, Hegde S, Park MD, Maier BB, Troncoso L, Berichel JL, Hamon P, Belabed M, Mattiuz R, Hennequin C, Chin T, et al. An IL-4 signaling axis in bone marrow drives pro-tumorigenic myelopoiesis. Nature. doi: 10.1038/s41586-023-06797-9. In Press.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06797-9</ArticleId><ArticleId IdType="pmc">PMC11189607</ArticleId><ArticleId IdType="pubmed">38057662</ArticleId></ArticleIdList></Reference><Reference><Citation>Leader AM, Grout JA, Maier BB, Nabet BY, Park MD, Tabachnikova A, Chang C, Walker L, Lansky A, Le Berichel J, Troncoso L, et al. Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification. Cancer Cell. 2021;39:1594&#x2013;1609.:e12. doi: 10.1016/j.ccell.2021.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccell.2021.10.009</ArticleId><ArticleId IdType="pmc">PMC8728963</ArticleId><ArticleId IdType="pubmed">34767762</ArticleId></ArticleIdList></Reference><Reference><Citation>Casanova-Acebes M, Dalla E, Leader AM, LeBerichel J, Nikolic J, Morales BM, Brown M, Chang C, Troncoso L, Chen ST, Sastre-Perona A, et al. Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells. Nature. 2021;595:578&#x2013;584. doi: 10.1038/s41586-021-03651-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03651-8</ArticleId><ArticleId IdType="pmc">PMC8923521</ArticleId><ArticleId IdType="pubmed">34135508</ArticleId></ArticleIdList></Reference><Reference><Citation>Loyher P-L, Hamon P, Laviron M, Meghraoui-Kheddar A, Goncalves E, Deng Z, Torstensson S, Bercovici N, Baudesson de Chanville C, Combadi&#xe8;re B, Geissmann F, et al. Macrophages of distinct origins contribute to tumor development in the lung. J Exp Med. 2018;215:2536&#x2013;2553. doi: 10.1084/jem.20180534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20180534</ArticleId><ArticleId IdType="pmc">PMC6170177</ArticleId><ArticleId IdType="pubmed">30201786</ArticleId></ArticleIdList></Reference><Reference><Citation>Park MD, Reyes-Torres I, LeBerichel J, Hamon P, LaMarche NM, Hegde S, Belabed M, Troncoso L, Grout JA, Magen A, Humblin E, et al. TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer. Nat Immunol. 2023;24:792&#x2013;801. doi: 10.1038/s41590-023-01475-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01475-4</ArticleId><ArticleId IdType="pmc">PMC11088947</ArticleId><ArticleId IdType="pubmed">37081148</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortez-Retamozo V, Etzrodt M, Newton A, Rauch PJ, Chudnovskiy A, Berger C, Ryan H, Iwamoto Y, Marinelli B, Gorbatov R, Forghani R, et al. Origins of tumor-associated macrophages and neutrophils. Proc Natl Acad Sci U S A. 2012;109:2491&#x2013;2496. doi: 10.1073/pnas.1113744109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1113744109</ArticleId><ArticleId IdType="pmc">PMC3289379</ArticleId><ArticleId IdType="pubmed">22308361</ArticleId></ArticleIdList></Reference><Reference><Citation>Barisas DAG, Kabir AU, Wu J, Krchma K, Kim M, Subramanian M, Zinselmeyer BH, Stewart CL, Choi K. Tumor-derived interleukin-1&#x3b1; and leukemia inhibitory factor promote extramedullary hematopoiesis. PLoS Biol. 2023;21:e3001746. doi: 10.1371/journal.pbio.3001746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3001746</ArticleId><ArticleId IdType="pmc">PMC10155962</ArticleId><ArticleId IdType="pubmed">37134077</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikkema L, Ram&#xed;rez-Su&#xe1;stegui C, Strobl DC, Gillett TE, Zappia L, Madissoon E, Markov NS, Zaragosi L-E, Ji Y, Ansari M, Arguel M-J, et al. An integrated cell atlas of the lung in health and disease. Nat Med. 2023;29:1563&#x2013;1577. doi: 10.1038/s41591-023-02327-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02327-2</ArticleId><ArticleId IdType="pmc">PMC10287567</ArticleId><ArticleId IdType="pubmed">37291214</ArticleId></ArticleIdList></Reference><Reference><Citation>Mende N, Bastos HP, Santoro A, Mahbubani KT, Ciaurro V, Calderbank EF, Quiroga Londo&#xf1;o M, Sham K, Mantica G, Morishima T, Mitchell E, et al. Unique molecular and functional features of extramedullary hematopoietic stem and progenitor cell reservoirs in humans. Blood. 2022;139:3387&#x2013;3401. doi: 10.1182/blood.2021013450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2021013450</ArticleId><ArticleId IdType="pmc">PMC7612845</ArticleId><ArticleId IdType="pubmed">35073399</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W-C, Sun H-W, Chen H-T, Liang J, Yu X-J, Wu C, Wang Z, Zheng L. Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients. Proc Natl Acad Sci U S A. 2014;111:4221&#x2013;4226. doi: 10.1073/pnas.1320753111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1320753111</ArticleId><ArticleId IdType="pmc">PMC3964061</ArticleId><ArticleId IdType="pubmed">24591638</ArticleId></ArticleIdList></Reference><Reference><Citation>Lefran&#xe7;ais E, Ortiz-Mu&#xf1;oz G, Caudrillier A, Mallavia B, Liu F, Sayah DM, Thornton EE, Headley MB, David T, Coughlin SR, Krummel MF, et al. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature. 2017;544:105&#x2013;109. doi: 10.1038/nature21706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21706</ArticleId><ArticleId IdType="pmc">PMC5663284</ArticleId><ArticleId IdType="pubmed">28329764</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson KG, Mayer-Barber K, Sung H, Beura L, James BR, Taylor JJ, Qunaj L, Griffith TS, Vezys V, Barber DL, Masopust D. Intravascular staining for discrimination of vascular and tissue leukocytes. Nat Protoc. 2014;9:209&#x2013;222. doi: 10.1038/nprot.2014.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2014.005</ArticleId><ArticleId IdType="pmc">PMC4428344</ArticleId><ArticleId IdType="pubmed">24385150</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamon P, Loyher P-L, Baudesson de Chanville C, Licata F, Combadi&#xe8;re C, Boissonnas A. CX3CR1-dependent endothelial margination modulates Ly6Chigh monocyte systemic deployment upon inflammation in mice. Blood. 2017;129:1296&#x2013;1307.</Citation><ArticleIdList><ArticleId IdType="pubmed">28011675</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur A, Webster MR, Marchbank K, Behera R, Ndoye A, Kugel CH, 3rd, Dang VM, Appleton J, O&#x2019;Connell MP, Cheng P, Valiga AA, et al. sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance. Nature. 2016;532:250&#x2013;254. doi: 10.1038/nature17392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature17392</ArticleId><ArticleId IdType="pmc">PMC4833579</ArticleId><ArticleId IdType="pubmed">27042933</ArticleId></ArticleIdList></Reference><Reference><Citation>Fane ME, Chhabra Y, Alicea GM, Maranto DA, Douglass SM, Webster MR, Rebecca VW, Marino GE, Almeida F, Ecker BL, Zabransky DJ, et al. Stromal changes in the aged lung induce an emergence from melanoma dormancy. Nature. 2022;606:396&#x2013;405. doi: 10.1038/s41586-022-04774-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04774-2</ArticleId><ArticleId IdType="pmc">PMC9554951</ArticleId><ArticleId IdType="pubmed">35650435</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong Z, Li Q, Shi J, Li P, Hua L, Shultz LD, Ren G. Immunosuppressive reprogramming of neutrophils by lung mesenchymal cells promotes breast cancer metastasis. Sci Immunol. 2023;8:eadd5204. doi: 10.1126/sciimmunol.add5204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.add5204</ArticleId><ArticleId IdType="pmc">PMC10067025</ArticleId><ArticleId IdType="pubmed">36800412</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuribayashi W, Oshima M, Itokawa N, Koide S, Nakajima-Takagi Y, Yamashita M, Yamazaki S, Rahmutulla B, Miura F, Ito T, Kaneda A, et al. Limited rejuvenation of aged hematopoietic stem cells in young bone marrow niche. J Exp Med. 2021;218 doi: 10.1084/jem.20192283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20192283</ArticleId><ArticleId IdType="pmc">PMC7690939</ArticleId><ArticleId IdType="pubmed">33231616</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho TT, Dellorusso PV, Verovskaya EV, Bakker ST, Flach J, Smith LK, Ventura PB, Lansinger OM, H&#xe9;rault A, Zhang SY, Kang Y-A, et al. Aged hematopoietic stem cells are refractory to bloodborne systemic rejuvenation interventions. J Exp Med. 2021;218 doi: 10.1084/jem.20210223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20210223</ArticleId><ArticleId IdType="pmc">PMC8155813</ArticleId><ArticleId IdType="pubmed">34032859</ArticleId></ArticleIdList></Reference><Reference><Citation>Itokawa N, Oshima M, Koide S, Takayama N, Kuribayashi W, Nakajima-Takagi Y, Aoyama K, Yamazaki S, Yamaguchi K, Furukawa Y, Eto K, et al. Epigenetic traits inscribed in chromatin accessibility in aged hematopoietic stem cells. Nat Commun. 2022;13:2691. doi: 10.1038/s41467-022-30440-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30440-2</ArticleId><ArticleId IdType="pmc">PMC9110722</ArticleId><ArticleId IdType="pubmed">35577813</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwok I, Becht E, Xia Y, Ng M, Teh YC, Tan L, Evrard M, Li JLY, Tran HTN, Tan Y, Liu D, et al. Combinatorial Single-Cell Analyses of Granulocyte-Monocyte Progenitor Heterogeneity Reveals an Early Uni-potent Neutrophil Progenitor. Immunity. 2020;53:303&#x2013;318.:e5.</Citation><ArticleIdList><ArticleId IdType="pubmed">32579887</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor PR, Reid DM, Heinsbroek SEM, Brown GD, Gordon S, Wong SYC. Dectin-2 is predominantly myeloid restricted and exhibits unique activation-dependent expression on maturing inflammatory monocytes elicited in vivo. Eur J Immunol. 2005;35:2163&#x2013;2174.</Citation><ArticleIdList><ArticleId IdType="pubmed">15940672</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarjour NN, Schwarzkopf EA, Bradstreet TR, Shchukina I, Lin C-C, Huang SC-C, Lai C-W, Cook ME, Taneja R, Stappenbeck TS, Randolph GJ, et al. Bhlhe40 mediates tissue-specific control of macrophage proliferation in homeostasis and type 2 immunity. Nat Immunol. 2019;20:687&#x2013;700. doi: 10.1038/s41590-019-0382-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-019-0382-5</ArticleId><ArticleId IdType="pmc">PMC6531324</ArticleId><ArticleId IdType="pubmed">31061528</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook ME, Jarjour NN, Lin C-C, Edelson BT. Transcription Factor Bhlhe40 in Immunity and Autoimmunity. Trends Immunol. 2020;41:1023&#x2013;1036. doi: 10.1016/j.it.2020.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2020.09.002</ArticleId><ArticleId IdType="pmc">PMC7606821</ArticleId><ArticleId IdType="pubmed">33039338</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotzin JJ, Spencer SP, McCright SJ, Kumar DBU, Collet MA, Mowel WK, Elliott EN, Uyar A, Makiya MA, Dunagin MC, Harman CCD, et al. The long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan. Nature. 2016;537:239&#x2013;243. doi: 10.1038/nature19346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature19346</ArticleId><ArticleId IdType="pmc">PMC5161578</ArticleId><ArticleId IdType="pubmed">27525555</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Z, Aguilera F, Ramdas B, Daulatabad SV, Srivastava R, Kotzin JJ, Carroll M, Wertheim G, Williams A, Janga SC, Zhang C, et al. Targeting Bim via a lncRNA Morrbid Regulates the Survival of Preleukemic and Leukemic Cells. Cell Rep. 2020;31:107816. doi: 10.1016/j.celrep.2020.107816.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.107816</ArticleId><ArticleId IdType="pmc">PMC7371151</ArticleId><ArticleId IdType="pubmed">32579941</ArticleId></ArticleIdList></Reference><Reference><Citation>Koncina E, Nurmik M, Pozdeev VI, Gilson C, Tsenkova M, Begaj R, Stang S, Gaigneaux A, Weindorfer C, Rodriguez F, Schmoetten M, et al. IL1R1+ cancer-associated fibroblasts drive tumor development and immunosuppression in colorectal cancer. Nat Commun. 2023;14:1&#x2013;17. doi: 10.1038/s41467-023-39953-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-39953-w</ArticleId><ArticleId IdType="pmc">PMC10352362</ArticleId><ArticleId IdType="pubmed">37460545</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd DF, Allen EK, Randolph AG, Guo X-ZJ, Weng Y, Sanders CJ, Bajracharya R, Lee NK, Guy CS, Vogel P, Guan W, et al. Exuberant fibroblast activity compromises lung function via ADAMTS4. Nature. 2020;587:466&#x2013;471. doi: 10.1038/s41586-020-2877-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2877-5</ArticleId><ArticleId IdType="pmc">PMC7883627</ArticleId><ArticleId IdType="pubmed">33116313</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffith JW, Faustino LD, Cottrell VI, Nepal K, Hariri LP, Chiu RS-Y, Jones MC, Jul&#xe9; A, Gabay C, Luster AD. Regulatory T cell-derived IL-1Ra suppresses the innate response to respiratory viral infection. Nat Immunol. 2023:1&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11887468</ArticleId><ArticleId IdType="pubmed">37945820</ArticleId></ArticleIdList></Reference><Reference><Citation>Orjalo AV, Bhaumik D, Gengler BK, Scott GK, Campisi J. Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc Natl Acad Sci U S A. 2009;106:17031&#x2013;17036. doi: 10.1073/pnas.0905299106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0905299106</ArticleId><ArticleId IdType="pmc">PMC2761322</ArticleId><ArticleId IdType="pubmed">19805069</ArticleId></ArticleIdList></Reference><Reference><Citation>Suwara MI, Green NJ, Borthwick LA, Mann J, Mayer-Barber KD, Barron L, Corris PA, Farrow SN, Wynn TA, Fisher AJ, Mann DA. IL-1&#x3b1; released from damaged epithelial cells is sufficient and essential to trigger inflammatory responses in human lung fibroblasts. Mucosal Immunol. 2013;7:684&#x2013;693. doi: 10.1038/mi.2013.87.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2013.87</ArticleId><ArticleId IdType="pmc">PMC3931585</ArticleId><ArticleId IdType="pubmed">24172847</ArticleId></ArticleIdList></Reference><Reference><Citation>Laberge R-M, Sun Y, Orjalo AV, Patil CK, Freund A, Zhou L, Curran SC, Davalos AR, Wilson-Edell KA, Liu S, Limbad C, et al. MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat Cell Biol. 2015;17:1049&#x2013;1061. doi: 10.1038/ncb3195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb3195</ArticleId><ArticleId IdType="pmc">PMC4691706</ArticleId><ArticleId IdType="pubmed">26147250</ArticleId></ArticleIdList></Reference><Reference><Citation>Osei ET, Noordhoek JA, Hackett TL, Spanjer AIR, Timens W, Brandsma C-A, Heijink IH. Interleukin-1&#x3b1; drives the dysfunctional cross-talk of the airway epithelium and lung fibroblasts in COPD. Eur Respir J. 2016;48:359&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pubmed">27418555</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagareddy PR, Kraakman M, Masters SL, Stirzaker RA, Gorman DJ, Grant RW, Dragoljevic D, Hong ES, Abdel-Latif A, Smyth SS, Choi SH, et al. Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity. Cell Metab. 2014;19:821&#x2013;835. doi: 10.1016/j.cmet.2014.03.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2014.03.029</ArticleId><ArticleId IdType="pmc">PMC4048939</ArticleId><ArticleId IdType="pubmed">24807222</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitroulis I, Ruppova K, Wang B, Chen L-S, Grzybek M, Grinenko T, Eugster A, Troullinaki M, Palladini A, Kourtzelis I, Chatzigeorgiou A, et al. Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity. Cell. 2018;172:147&#x2013;161.:e12. doi: 10.1016/j.cell.2017.11.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.11.034</ArticleId><ArticleId IdType="pmc">PMC5766828</ArticleId><ArticleId IdType="pubmed">29328910</ArticleId></ArticleIdList></Reference><Reference><Citation>Christ A, G&#xfc;nther P, Lauterbach MAR, Duewell P, Biswas D, Pelka K, Scholz CJ, Oosting M, Haendler K, Ba&#xdf;ler K, Klee K, et al. Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming. Cell. 2018;172:162&#x2013;175.:e14. doi: 10.1016/j.cell.2017.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.12.013</ArticleId><ArticleId IdType="pmc">PMC6324559</ArticleId><ArticleId IdType="pubmed">29328911</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietras EM, Mirantes-Barbeito C, Fong S, Loeffler D, Kovtonyuk LV, Zhang S, Lakshminarasimhan R, Chin CP, Techner J-M, Will B, Nerlov C, et al. Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal. Nat Cell Biol. 2016;18:607&#x2013;618. doi: 10.1038/ncb3346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb3346</ArticleId><ArticleId IdType="pmc">PMC4884136</ArticleId><ArticleId IdType="pubmed">27111842</ArticleId></ArticleIdList></Reference><Reference><Citation>Higa KC, Goodspeed A, Chavez JS, De Dominici M, Danis E, Zaberezhnyy V, Rabe JL, Tenen DG, Pietras EM, DeGregori J. Chronic interleukin-1 exposure triggers selection for Cebpa-knockout multipotent hematopoietic progenitors. J Exp Med. 2021;218 doi: 10.1084/jem.20200560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20200560</ArticleId><ArticleId IdType="pmc">PMC8094119</ArticleId><ArticleId IdType="pubmed">33914855</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Wang H, Yu X, Saha G, Kalafati L, Ioannidis C, Mitroulis I, Netea MG, Chavakis T, Hajishengallis G. Maladaptive innate immune training of myelopoiesis links inflammatory comorbidities. Cell. 2022;185:1709&#x2013;1727.:e18. doi: 10.1016/j.cell.2022.03.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.03.043</ArticleId><ArticleId IdType="pmc">PMC9106933</ArticleId><ArticleId IdType="pubmed">35483374</ArticleId></ArticleIdList></Reference><Reference><Citation>Caiado F, Kovtonyuk LV, Gonullu NG, Fullin J, Boettcher S, Manz MG. Aging drives Tet2+/- clonal hematopoiesis via IL-1 signaling. Blood. 2023;141:886&#x2013;903. doi: 10.1182/blood.2022016835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2022016835</ArticleId><ArticleId IdType="pmc">PMC10651783</ArticleId><ArticleId IdType="pubmed">36379023</ArticleId></ArticleIdList></Reference><Reference><Citation>DuPage M, Dooley AL, Jacks T. Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat Protoc. 2009;4:1064&#x2013;1072. doi: 10.1038/nprot.2009.95.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2009.95</ArticleId><ArticleId IdType="pmc">PMC2757265</ArticleId><ArticleId IdType="pubmed">19561589</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73:233&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pubmed">36856579</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovtonyuk LV, Caiado F, Garcia-Martin S, Manz E-M, Helbling P, Takizawa H, Boettcher S, Al-Shahrour F, Nombela-Arrieta C, Slack E, Manz MG. IL-1 mediates microbiome-induced inflammaging of hematopoietic stem cells in mice. Blood. 2022;139:44&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">34525198</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun D, Luo M, Jeong M, Rodriguez B, Xia Z, Hannah R, Wang H, Le T, Faull KF, Chen R, Gu H, et al. Epigenomic profiling of young and aged HSCs reveals concerted changes during aging that reinforce self-renewal. Cell Stem Cell. 2014;14:673&#x2013;688. doi: 10.1016/j.stem.2014.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2014.03.002</ArticleId><ArticleId IdType="pmc">PMC4070311</ArticleId><ArticleId IdType="pubmed">24792119</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessler MD, Damask A, O&#x2019;Keeffe S, Banerjee N, Li D, Watanabe K, Marketta A, Van Meter M, Semrau S, Horowitz J, Tang J, et al. Common and rare variant associations with clonal haematopoiesis phenotypes. Nature. 2022;612:301&#x2013;309. doi: 10.1038/s41586-022-05448-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05448-9</ArticleId><ArticleId IdType="pmc">PMC9713173</ArticleId><ArticleId IdType="pubmed">36450978</ArticleId></ArticleIdList></Reference><Reference><Citation>Oetjen KA, Lindblad KE, Goswami M, Gui G, Dagur PK, Lai C, Dillon LW, McCoy JP, Hourigan CS. Human bone marrow assessment by single-cell RNA sequencing, mass cytometry, and flow cytometry. JCI Insight. 2018;3 doi: 10.1172/jci.insight.124928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.124928</ArticleId><ArticleId IdType="pmc">PMC6328018</ArticleId><ArticleId IdType="pubmed">30518681</ArticleId></ArticleIdList></Reference><Reference><Citation>Ainciburu M, Ezponda T, Berastegui N, Alfonso-Pierola A, Vilas-Zornoza A, San Martin-Uriz P, Alignani D, Lamo-Espinosa J, San-Julian M, Jim&#xe9;nez-Solas T, Lopez F, et al. Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single-cell resolution. Elife. 2023;12 doi: 10.7554/eLife.79363.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.79363</ArticleId><ArticleId IdType="pmc">PMC9904760</ArticleId><ArticleId IdType="pubmed">36629404</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadad N, Masser DR, Logan S, Wronowski B, Mangold CA, Clark N, Otalora L, Unnikrishnan A, Ford MM, Giles CB, Wren JD, et al. Absence of genomic hypomethylation or regulation of cytosine-modifying enzymes with aging in male and female mice. Epigenetics Chromatin. 2016;9:30. doi: 10.1186/s13072-016-0080-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13072-016-0080-6</ArticleId><ArticleId IdType="pmc">PMC4942942</ArticleId><ArticleId IdType="pubmed">27413395</ArticleId></ArticleIdList></Reference><Reference><Citation>Midic D, Rinke J, Perner F, M&#xfc;ller V, Hinze A, Pester F, Landschulze J, Ernst J, Gruhn B, Matziolis G, Heidel FH, et al. Prevalence and dynamics of clonal hematopoiesis caused by leukemia-associated mutations in elderly individuals without hematologic disorders. Leukemia. 2020;34:2198&#x2013;2205. doi: 10.1038/s41375-020-0869-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41375-020-0869-y</ArticleId><ArticleId IdType="pmc">PMC7387320</ArticleId><ArticleId IdType="pubmed">32457355</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang CR, Ostrander EL, Kukhar O, Mallaney C, Sun J, Haussler E, Celik H, Koh WK, King KY, Gontarz P, Challen GA. Txnip Enhances Fitness of Dnmt3a-Mutant Hematopoietic Stem Cells via p21. Blood Cancer Discov. 2022;3:220&#x2013;239. doi: 10.1158/2643-3230.BCD-21-0132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2643-3230.BCD-21-0132</ArticleId><ArticleId IdType="pmc">PMC9414740</ArticleId><ArticleId IdType="pubmed">35394496</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong M, Sun D, Luo M, Huang Y, Challen GA, Rodriguez B, Zhang X, Chavez L, Wang H, Hannah R, Kim S-B, et al. Large conserved domains of low DNA methylation maintained by Dnmt3a. Nat Genet. 2014;46:17&#x2013;23. doi: 10.1038/ng.2836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2836</ArticleId><ArticleId IdType="pmc">PMC3920905</ArticleId><ArticleId IdType="pubmed">24270360</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng R, Friedman AD, Small D. Targeted inhibition of FLT3 overcomes the block to myeloid differentiation in 32Dcl3 cells caused by expression of FLT3/ITD mutations. Blood. 2002;100:4154&#x2013;4161.</Citation><ArticleIdList><ArticleId IdType="pubmed">12393674</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeder T, Just U. Notch signalling via RBP-J promotes myeloid differentiation. EMBO J. 2000;19:2558&#x2013;2568. doi: 10.1093/emboj/19.11.2558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/19.11.2558</ArticleId><ArticleId IdType="pmc">PMC212745</ArticleId><ArticleId IdType="pubmed">10835354</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng Y, Carrelha J, Drissen R, Ren X, Zhang B, Gambardella A, Valletta S, Thongjuea S, Jacobsen SE, Nerlov C. Epigenetic programming defines haematopoietic stem cell fate restriction. Nat Cell Biol. 2023;25:812&#x2013;822.</Citation><ArticleIdList><ArticleId IdType="pubmed">37127714</ArticleId></ArticleIdList></Reference><Reference><Citation>Menezes AC, Jones R, Shrestha A, Nicholson R, Leckenby A, Azevedo A, Davies S, Baker S, Gilkes AF, Darley RL, Tonks A. Increased expression of RUNX3 inhibits normal human myeloid development. Leukemia. 2022;36:1769&#x2013;1780. doi: 10.1038/s41375-022-01577-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41375-022-01577-2</ArticleId><ArticleId IdType="pmc">PMC9252899</ArticleId><ArticleId IdType="pubmed">35490198</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito-Reis CA, Balise VD, Pascetti EM, Jiminez M, Gillette JM. Tetraspanin CD82 regulates S1PR1-mediated hematopoietic stem and progenitor cell mobilization. Stem Cell Reports. 2021;16:2422&#x2013;2431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8514849</ArticleId><ArticleId IdType="pubmed">34534447</ArticleId></ArticleIdList></Reference><Reference><Citation>Hmama Z, Nandan D, Sly L, Knutson KL, Herrera-Velit P, Reiner NE. 1alpha, 25-dihydroxyvitamin D(3)-induced myeloid cell differentiation is regulated by a vitamin D receptor-phosphatidylinositol 3-kinase signaling complex. J Exp Med. 1999;190:1583&#x2013;1594. doi: 10.1084/jem.190.11.1583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.190.11.1583</ArticleId><ArticleId IdType="pmc">PMC2195730</ArticleId><ArticleId IdType="pubmed">10587349</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakahashi K, Minagawa K, Kawano Y, Kawano H, Suzuki T, Ishii S, Sada A, Asada N, Sato M, Kato S, Shide K, et al. Vitamin D receptor&#x2013;mediated skewed differentiation of macrophages initiates myelofibrosis and subsequent osteosclerosis. Blood. 2019;133:1619&#x2013;1629.</Citation><ArticleIdList><ArticleId IdType="pubmed">30718230</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y-Y, Liu Y-F, Liu Y-D, Deng X-H, Zhou J. IRF7 suppresses hematopoietic regeneration under stress via CXCR4. Stem Cells. 2021;39:183&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pubmed">33252829</ArticleId></ArticleIdList></Reference><Reference><Citation>Guryanova OA, Lieu YK, Garrett-Bakelman FE, Spitzer B, Glass JL, Shank K, Martinez ABV, Rivera SA, Durham BH, Rapaport F, Keller MD, et al. Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cells. Leukemia. 2016;30:1133&#x2013;1142. doi: 10.1038/leu.2015.358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/leu.2015.358</ArticleId><ArticleId IdType="pmc">PMC4856586</ArticleId><ArticleId IdType="pubmed">26710888</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauch PJ, Gopakumar J, Silver AJ, Nachun D, Ahmad H, McConkey M, Nakao T, Bosse M, Rentz T, Vivanco Gonzalez N, Greenwald NF, et al. Loss-of-function mutations in Dnmt3a and Tet2 lead to accelerated atherosclerosis and concordant macrophage phenotypes. Nature Cardiovascular Research. 2023;2:805&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pubmed">39196062</ArticleId></ArticleIdList></Reference><Reference><Citation>Alaluf E, Vokaer B, Detavernier A, Azouz A, Splittgerber M, Carrette A, Boon L, Libert F, Soares M, Le Moine A, Goriely S. Heme oxygenase-1 orchestrates the immunosuppressive program of tumor-associated macrophages. JCI Insight. 2020;5 doi: 10.1172/jci.insight.133929.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.133929</ArticleId><ArticleId IdType="pmc">PMC7308058</ArticleId><ArticleId IdType="pubmed">32369450</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y-J, Li G-N, Li X-J, Wei L-X, Fu M-J, Cheng Z-L, Yang Z, Zhu G-Q, Wang X-D, Zhang C, Zhang J-Y, et al. Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy. Science Advances. 2023;9:eadg0654. doi: 10.1126/sciadv.adg0654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.adg0654</ArticleId><ArticleId IdType="pmc">PMC10146892</ArticleId><ArticleId IdType="pubmed">37115931</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills EL, Ryan DG, Prag HA, Dikovskaya D, Menon D, Zaslona Z, Jedrychowski MP, Costa ASH, Higgins M, Hams E, Szpyt J, et al. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature. 2018;556:113&#x2013;117. doi: 10.1038/nature25986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature25986</ArticleId><ArticleId IdType="pmc">PMC6047741</ArticleId><ArticleId IdType="pubmed">29590092</ArticleId></ArticleIdList></Reference><Reference><Citation>Cobo I, Tanaka TN, Chandra Mangalhara K, Lana A, Yeang C, Han C, Schlachetzki J, Challcombe J, Fixsen BR, Sakai M, Li RZ, et al. DNA methyltransferase 3 alpha and TET methylcytosine dioxygenase 2 restrain mitochondrial DNA-mediated interferon signaling in macrophages. Immunity. 2022;55:1386&#x2013;1401.:e10. doi: 10.1016/j.immuni.2022.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.06.022</ArticleId><ArticleId IdType="pmc">PMC9718507</ArticleId><ArticleId IdType="pubmed">35931086</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim PG, Niroula A, Shkolnik V, McConkey M, Lin AE, S&#x142;abicki M, Kemp JP, Bick A, Gibson CJ, Griffin G, Sekar A, et al. Dnmt3a-mutated clonal hematopoiesis promotes osteoporosis. J Exp Med. 2021;218 doi: 10.1084/jem.20211872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20211872</ArticleId><ArticleId IdType="pmc">PMC8552148</ArticleId><ArticleId IdType="pubmed">34698806</ArticleId></ArticleIdList></Reference><Reference><Citation>SanMiguel JM, Eudy E, Loberg MA, Young KA, Mistry JJ, Mujica KD, Schwartz LS, Stearns TM, Challen GA, Trowbridge JJ. Distinct Tumor Necrosis Factor Alpha Receptors Dictate Stem Cell Fitness versus Lineage Output in Dnmt3a-Mutant Clonal Hematopoiesis. Cancer Discov. 2022;12:2763&#x2013;2773. doi: 10.1158/2159-8290.CD-22-0086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-22-0086</ArticleId><ArticleId IdType="pmc">PMC9716249</ArticleId><ArticleId IdType="pubmed">36169447</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita M, Passegu&#xe9; E. TNF-&#x3b1; Coordinates Hematopoietic Stem Cell Survival and Myeloid Regeneration. Cell Stem Cell. 2019;25:357&#x2013;372.:e7. doi: 10.1016/j.stem.2019.05.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2019.05.019</ArticleId><ArticleId IdType="pmc">PMC6733032</ArticleId><ArticleId IdType="pubmed">31230859</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lung Cancer Cohort Consortium. The blood proteome of imminent lung cancer diagnosis. Nat Commun. 2023;14:1&#x2013;12. doi: 10.1038/s41467-023-37979-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-37979-8</ArticleId><ArticleId IdType="pmc">PMC10235023</ArticleId><ArticleId IdType="pubmed">37264016</ArticleId></ArticleIdList></Reference><Reference><Citation>Dou Z, Ghosh K, Vizioli MG, Zhu J, Sen P, Wangensteen KJ, Simithy J, Lan Y, Lin Y, Zhou Z, Capell BC, et al. Cytoplasmic chromatin triggers inflammation in senescence and cancer. Nature. 2017;550:402&#x2013;406. doi: 10.1038/nature24050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature24050</ArticleId><ArticleId IdType="pmc">PMC5850938</ArticleId><ArticleId IdType="pubmed">28976970</ArticleId></ArticleIdList></Reference><Reference><Citation>Luksch H, Stinson WA, Platt DJ, Qian W, Kalugotla G, Miner CA, Bennion BG, Gerbaulet A, R&#xf6;sen-Wolff A, Miner JJ. STING-associated lung disease in mice relies on T cells but not type I interferon. J Allergy Clin Immunol. 2019;144:254&#x2013;266.:e8. doi: 10.1016/j.jaci.2019.01.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2019.01.044</ArticleId><ArticleId IdType="pmc">PMC6612314</ArticleId><ArticleId IdType="pubmed">30772497</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Ghosh S, Vaidya T, Bammidi S, Huang C, Shang P, Nair AP, Chowdhury O, Stepicheva NA, Strizhakova A, Hose S, et al. Activated cGAS/STING signaling elicits endothelial cell senescence in early diabetic retinopathy. JCI Insight. 2023 Jun;8 doi: 10.1172/jci.insight.168945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.168945</ArticleId><ArticleId IdType="pmc">PMC10371250</ArticleId><ArticleId IdType="pubmed">37345657</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X, Ma G, Li X, Zhao J, Zhao Z, Zeng J. Activation of innate immune cGAS-STING pathway contributes to Alzheimer&#x2019;s pathogenesis in 5&#xd7;FAD mice. Nature Aging. 2023;3:202&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pubmed">37118112</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiappinelli KB, Strissel PL, Desrichard A, Li H, Henke C, Akman B, Hein A, Rote NS, Cope LM, Snyder A, Makarov V, et al. Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses. Cell. 2015;162:974&#x2013;986. doi: 10.1016/j.cell.2015.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.07.011</ArticleId><ArticleId IdType="pmc">PMC4556003</ArticleId><ArticleId IdType="pubmed">26317466</ArticleId></ArticleIdList></Reference><Reference><Citation>Roulois D, Loo Yau H, Singhania R, Wang Y, Danesh A, Shen SY, Han H, Liang G, Jones PA, Pugh TJ, O&#x2019;Brien C, et al. DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts. Cell. 2015;162:961&#x2013;973. doi: 10.1016/j.cell.2015.07.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.07.056</ArticleId><ArticleId IdType="pmc">PMC4843502</ArticleId><ArticleId IdType="pubmed">26317465</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheller M, Ludwig AK, G&#xf6;llner S, Rohde C, Kr&#xe4;mer S, St&#xe4;ble S, Janssen M, M&#xfc;ller J-A, He L, B&#xe4;umer N, Arnold C, et al. Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry response. Nat Cancer. 2021;2:527&#x2013;544.</Citation><ArticleIdList><ArticleId IdType="pubmed">35122024</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong T, Li J, Guo L, Cavalier M, Wang T, Dou Y, DeLaFuente A, Fang S, Guzman A, Wohlan K, Kapadia C, et al. TET2 modulates spatial relocalization of heterochromatin in aged hematopoietic stem and progenitor cells. Nat Aging. 2023 doi: 10.1038/s43587-023-00505-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43587-023-00505-y</ArticleId><ArticleId IdType="pmc">PMC11209854</ArticleId><ArticleId IdType="pubmed">37884767</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuroda E, Ozasa K, Temizoz B, Ohata K, Koo CX, Kanuma T, Kusakabe T, Kobari S, Horie M, Morimoto Y, Nakajima S, et al. Inhaled Fine Particles Induce Alveolar Macrophage Death and Interleukin-1&#x3b1; Release to Promote Inducible Bronchus-Associated Lymphoid Tissue Formation. Immunity. 2016;45:1299&#x2013;1310.</Citation><ArticleIdList><ArticleId IdType="pubmed">28002730</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsay J-CJ, Wu BG, Sulaiman I, Gershner K, Schluger R, Li Y, Yie T-A, Meyn P, Olsen E, Perez L, Franca B, et al. Lower Airway Dysbiosis Affects Lung Cancer Progression. Cancer Discov. 2021;11:293&#x2013;307. doi: 10.1158/2159-8290.CD-20-0263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-20-0263</ArticleId><ArticleId IdType="pmc">PMC7858243</ArticleId><ArticleId IdType="pubmed">33177060</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilley AE, Walters MS, Shaykhiev R, Crystal RG. Cilia dysfunction in lung disease. Annu Rev Physiol. 2015;77:379&#x2013;406. doi: 10.1146/annurev-physiol-021014-071931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-physiol-021014-071931</ArticleId><ArticleId IdType="pmc">PMC4465242</ArticleId><ArticleId IdType="pubmed">25386990</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker PM, MacFadyen JG, Thuren T, Everett BM, Libby P, Glynn RJ CANTOS Trial Group. Effect of interleukin-1&#x3b2; inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet. 2017;390:1833&#x2013;1842.</Citation><ArticleIdList><ArticleId IdType="pubmed">28855077</ArticleId></ArticleIdList></Reference><Reference><Citation>Garlanda C, Mantovani A. Interleukin-1 in tumor progression, therapy, and prevention. Cancer Cell. 2021;39:1023&#x2013;1027.</Citation><ArticleIdList><ArticleId IdType="pubmed">33989512</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong W, Li A, Liu Y, Xiao X, Christiani DC, Hung RJ, McKay J, Field J, Amos CI, Cheng C. Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors. Cancer Res. 2022;82:199&#x2013;209. doi: 10.1158/0008-5472.CAN-21-1903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-21-1903</ArticleId><ArticleId IdType="pmc">PMC8815061</ArticleId><ArticleId IdType="pubmed">34815255</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman PV, Mar BG, Lindsley RC, Mermel CH, Burtt N, Chavez A, Higgins JM, et al. Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes. N Engl J Med. 2014;371:2488&#x2013;2498. doi: 10.1056/NEJMoa1408617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1408617</ArticleId><ArticleId IdType="pmc">PMC4306669</ArticleId><ArticleId IdType="pubmed">25426837</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E, McConkey M, Gupta N, Gabriel S, Ardissino D, Baber U, et al. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease. N Engl J Med. 2017;377:111&#x2013;121. doi: 10.1056/NEJMoa1701719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1701719</ArticleId><ArticleId IdType="pmc">PMC6717509</ArticleId><ArticleId IdType="pubmed">28636844</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya R, Zekavat SM, Haessler J, Fornage M, Raffield L, Uddin MM, Bick AG, Niroula A, Yu B, Gibson C, Griffin G, et al. NHLBI Trans-Omics for Precision Medicine Program., P, Natarajan., AP, Reiner, Clonal Hematopoiesis Is Associated With Higher Risk of Stroke. Stroke. 2022;53:788&#x2013;797. doi: 10.1161/STROKEAHA.121.037388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.121.037388</ArticleId><ArticleId IdType="pmc">PMC8885769</ArticleId><ArticleId IdType="pubmed">34743536</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong WJ, Emdin C, Bick AG, Zekavat SM, Niroula A, Pirruccello JP, Dichtel L, Griffin G, Uddin MM, Gibson CJ, Kovalcik V, et al. Clonal haematopoiesis and risk of chronic liver disease. Nature. 2023;616:747&#x2013;754. doi: 10.1038/s41586-023-05857-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-05857-4</ArticleId><ArticleId IdType="pmc">PMC10405350</ArticleId><ArticleId IdType="pubmed">37046084</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlasschaert C, McNaughton AJM, Chong M, Cook EK, Hopman W, Kestenbaum B, Robinson-Cohen C, Garland J, Moran SM, Par&#xe9; G, Clase CM, et al. Association of Clonal Hematopoiesis of Indeterminate Potential with Worse Kidney Function and Anemia in Two Cohorts of Patients with Advanced Chronic Kidney Disease. J Am Soc Nephrol. 2022;33:985&#x2013;995. doi: 10.1681/ASN.2021060774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2021060774</ArticleId><ArticleId IdType="pmc">PMC9063886</ArticleId><ArticleId IdType="pubmed">35197325</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawoud AAZ, Gilbert RD, Tapper WJ, Cross NCP. Clonal myelopoiesis promotes adverse outcomes in chronic kidney disease. Leukemia. 2021;36:507&#x2013;515. doi: 10.1038/s41375-021-01382-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41375-021-01382-3</ArticleId><ArticleId IdType="pmc">PMC8807385</ArticleId><ArticleId IdType="pubmed">34413458</ArticleId></ArticleIdList></Reference><Reference><Citation>Ershler WB, Stewart JA, Hacker MP, Moore AL, Tindle BH. B16 murine melanoma and aging: slower growth and longer survival in old mice. JNCI. 1984a;72:161&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">6582296</ArticleId></ArticleIdList></Reference><Reference><Citation>Ershler WB, Gamelli RL, Moore AL, Hacker MP, Blow AJ. Experimental tumors and aging: local factors that may account for the observed age advantage in the B16 murine melanoma model. Experimental Gerontology. 1984b;19:367&#x2013;376.</Citation><ArticleIdList><ArticleId IdType="pubmed">6519208</ArticleId></ArticleIdList></Reference><Reference><Citation>Ershler WB, Moore AL, Shore H, Gamelli RL. Transfer of age-associated restrained tumor growth in mice by old-to-young bone marrow transplantation. Cancer Res. 1984c;44:5677&#x2013;5680.</Citation><ArticleIdList><ArticleId IdType="pubmed">6388828</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur A, Webster MR, Marchbank K, Behera R, Ndoye A, Kugel CH, 3rd, Dang VM, Appleton J, O&#x2019;Connell MP, Cheng P, Valiga AA, et al. sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance. Nature. 2016;532:250&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4833579</ArticleId><ArticleId IdType="pubmed">27042933</ArticleId></ArticleIdList></Reference><Reference><Citation>Fane ME, Chhabra Y, Alicea GM, Maranto DA, Douglass SM, Webster MR, Rebecca VW, Marino GE, Almeida F, Ecker BL, Zabransky DJ, et al. Stromal changes in the aged lung induce an emergence from melanoma dormancy. Nature. 2022;606:396&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9554951</ArticleId><ArticleId IdType="pubmed">35650435</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhivaki D, Kennedy SN, Park J, Boriello F, Devant P, Cao A, Bahleda KM, Murphy S, McCabe C, Evavold CL, Chapman KL, et al. Correction of age-associated defects in dendritic cells enables CD4+ T cells to eradicate tumors. Cell. 2024 doi: 10.1016/j.cell.2024.05.026. 0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2024.05.026</ArticleId><ArticleId IdType="pmc">PMC11283364</ArticleId><ArticleId IdType="pubmed">38870946</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen ACY, Jaiswal S, Martinez D, Yerinde C, Ji K, Miranda V, Fung ME, Weiss SA, Zschummel M, Taguchi K, Garris CS, et al. The aged tumor microenvironment limits T cell control of cancer. Nat Immunol. 2024 doi: 10.1038/s41590-024-01828-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-024-01828-7</ArticleId><ArticleId IdType="pmc">PMC11500459</ArticleId><ArticleId IdType="pubmed">38745085</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuldiner EG, Karmakar S, Tsai MK, Hebert JD, Tang YJ, Andrejka L, Wang M, Detrick CR, Cai H, Tang R, Petrov DA, et al. Aging represses lung tumorigenesis and alters tumor suppression. bioRxiv. 2024:2024.05.28.596319</Citation></Reference><Reference><Citation>Zhuang X, Wang Q, Joost S, Ferrena A, Humphreys DT, Li Z, Blum M, Bastl K, Ding S, Landais Y, Zhan Y, et al. Aging limits stemness and tumorigenesis in the lung by reprogramming iron homeostasis. bioRxiv. 2024:2024.06.23.600305</Citation></Reference><Reference><Citation>Yousefzadeh MJ, Flores RR, Zhu Y, Schmiechen ZC, Brooks RW, Trussoni CE, Cui Y, Angelini L, Lee K-A, McGowan SJ, Burrack AL, et al. An aged immune system drives senescence and ageing of solid organs. Nature. 2021;594:100&#x2013;105. doi: 10.1038/s41586-021-03547-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03547-7</ArticleId><ArticleId IdType="pmc">PMC8684299</ArticleId><ArticleId IdType="pubmed">33981041</ArticleId></ArticleIdList></Reference><Reference><Citation>Prieto LI, Sturmlechner I, Graves SI, Zhang C, Goplen NP, Yi ES, Sun J, Li H, Baker DJ. Senescent alveolar macrophages promote early-stage lung tumorigenesis. Cancer Cell. 2023;41:1261&#x2013;1275.:e6. doi: 10.1016/j.ccell.2023.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccell.2023.05.006</ArticleId><ArticleId IdType="pmc">PMC10524974</ArticleId><ArticleId IdType="pubmed">37267954</ArticleId></ArticleIdList></Reference><Reference><Citation>Haston S, Gonzalez-Gualda E, Morsli S, Ge J, Reen V, Calderwood A, Moutsopoulos I, Panousopoulos L, Deletic P, Carreno G, Guiho R, et al. Clearance of senescent macrophages ameliorates tumorigenesis in KRAS-driven lung cancer. Cancer Cell. 2023;41:1242&#x2013;1260.:e6.</Citation><ArticleIdList><ArticleId IdType="pubmed">37267953</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcomat&#xe0; C, B&#xe4;rthel S, Widholz SA, Schneeweis C, Montero JJ, Toska A, Mir J, Kaltenbacher T, Heetmeyer J, Swietlik JJ, Cheng J-Y, et al. Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironment. Nat Cancer. 2022;3:318&#x2013;336. doi: 10.1038/s43018-021-00326-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43018-021-00326-1</ArticleId><ArticleId IdType="pmc">PMC7612546</ArticleId><ArticleId IdType="pubmed">35122074</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt C, Saur D, B&#xe4;rthel S, Falcomat&#xe0; C. Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer. J Vis Exp. 2022</Citation><ArticleIdList><ArticleId IdType="pubmed">36282716</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhainaut M, Rose SA, Akturk G, Wroblewska A, Nielsen SR, Park ES, Buckup M, Roudko V, Pia L, Sweeney R, Le Berichel J, et al. Spatial CRISPR genomics identifies regulators of the tumor microenvironment. Cell. 2022;185:1223&#x2013;1239.:e20. doi: 10.1016/j.cell.2022.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.02.015</ArticleId><ArticleId IdType="pmc">PMC8992964</ArticleId><ArticleId IdType="pubmed">35290801</ArticleId></ArticleIdList></Reference><Reference><Citation>Wroblewska A, Dhainaut M, Ben-Zvi B, Rose SA, Park ES, Amir E-AD, Bektesevic A, Baccarini A, Merad M, Rahman AH, Brown BD. Protein Barcodes Enable High-Dimensional Single-Cell CRISPR Screens. Cell. 2018;175:1141&#x2013;1155.:e16. doi: 10.1016/j.cell.2018.09.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.09.022</ArticleId><ArticleId IdType="pmc">PMC6319269</ArticleId><ArticleId IdType="pubmed">30343902</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>